Literature DB >> 32381657

Synaptic Communication in Brain Cancer.

Michelle Monje1.   

Abstract

Increasing evidence indicates that the nervous system plays a critical role in cancer progression. This is particularly true in cancers that occur within the central nervous system. Communication between neurons and cancer cells is a fundamental component of brain cancer pathophysiology, both for primary gliomas and for brain metastases. Neuronal activity drives growth of glial malignancies through secreted growth factors and through direct electrochemical synaptic communication. Reciprocally, brain cancers influence neuronal function, increasing neuronal activity and modulating the function of the circuits into which the cancer cells structurally and electrically integrate. Advancing understanding of neuron-cancer interactions will elucidate new therapeutic strategies for these presently lethal brain cancers. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 32381657      PMCID: PMC7367763          DOI: 10.1158/0008-5472.CAN-20-0646

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  NMDA receptors are expressed in oligodendrocytes and activated in ischaemia.

Authors:  Ragnhildur Káradóttir; Pauline Cavelier; Linda H Bergersen; David Attwell
Journal:  Nature       Date:  2005-12-22       Impact factor: 49.962

2.  Human glioma cells induce hyperexcitability in cortical networks.

Authors:  Susan L Campbell; Susan C Buckingham; Harald Sontheimer
Journal:  Epilepsia       Date:  2012-06-18       Impact factor: 5.864

3.  Identification of diverse astrocyte populations and their malignant analogs.

Authors:  Chia-Ching John Lin; Kwanha Yu; Asante Hatcher; Teng-Wei Huang; Hyun Kyoung Lee; Jeffrey Carlson; Matthew C Weston; Fengju Chen; Yiqun Zhang; Wenyi Zhu; Carrie A Mohila; Nabil Ahmed; Akash J Patel; Benjamin R Arenkiel; Jeffrey L Noebels; Chad J Creighton; Benjamin Deneen
Journal:  Nat Neurosci       Date:  2017-02-06       Impact factor: 24.884

4.  Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.

Authors:  Humsa S Venkatesh; Tessa B Johung; Viola Caretti; Alyssa Noll; Yujie Tang; Surya Nagaraja; Erin M Gibson; Christopher W Mount; Jai Polepalli; Siddhartha S Mitra; Pamelyn J Woo; Robert C Malenka; Hannes Vogel; Markus Bredel; Parag Mallick; Michelle Monje
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

5.  Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain.

Authors:  Erin M Gibson; David Purger; Christopher W Mount; Andrea K Goldstein; Grant L Lin; Lauren S Wood; Ingrid Inema; Sarah E Miller; Gregor Bieri; J Bradley Zuchero; Ben A Barres; Pamelyn J Woo; Hannes Vogel; Michelle Monje
Journal:  Science       Date:  2014-04-10       Impact factor: 47.728

Review 6.  Nerves in cancer.

Authors:  Ali H Zahalka; Paul S Frenette
Journal:  Nat Rev Cancer       Date:  2020-01-23       Impact factor: 60.716

7.  Motor skill learning requires active central myelination.

Authors:  Ian A McKenzie; David Ohayon; Huiliang Li; Joana Paes de Faria; Ben Emery; Koujiro Tohyama; William D Richardson
Journal:  Science       Date:  2014-10-17       Impact factor: 47.728

8.  Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes.

Authors:  Iben Lundgaard; Aryna Luzhynskaya; John H Stockley; Zhen Wang; Kimberley A Evans; Matthew Swire; Katrin Volbracht; Hélène O B Gautier; Robin J M Franklin; David Attwell; Ragnhildur T Káradóttir
Journal:  PLoS Biol       Date:  2013-12-31       Impact factor: 8.029

9.  Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.

Authors:  Humsa S Venkatesh; Lydia T Tam; Pamelyn J Woo; James Lennon; Surya Nagaraja; Shawn M Gillespie; Jing Ni; Damien Y Duveau; Patrick J Morris; Jean J Zhao; Craig J Thomas; Michelle Monje
Journal:  Nature       Date:  2017-09-20       Impact factor: 49.962

10.  Synaptic proximity enables NMDAR signalling to promote brain metastasis.

Authors:  Qiqun Zeng; Iacovos P Michael; Peng Zhang; Sadegh Saghafinia; Graham Knott; Wei Jiao; Brian D McCabe; José A Galván; Hugh P C Robinson; Inti Zlobec; Giovanni Ciriello; Douglas Hanahan
Journal:  Nature       Date:  2019-09-18       Impact factor: 69.504

View more
  6 in total

Review 1.  The dark side of synaptic proteins in tumours.

Authors:  Jing Li; Yalan Xu; Hai Zhu; Yin Wang; Peifeng Li; Dong Wang
Journal:  Br J Cancer       Date:  2022-05-27       Impact factor: 9.075

Review 2.  Repeated Awake Surgical Resection(s) for Recurrent Diffuse Low-Grade Gliomas: Why, When, and How to Reoperate?

Authors:  Hugues Duffau
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

3.  Tumor type, epilepsy burden, and seizure documentation: experiences at a single center neuro-oncology clinic.

Authors:  Omar Bushara; Alex Guzner; Elizabeth Bachman; Roger Stupp; Rimas V Lukas; Jessica W Templer
Journal:  Neurooncol Pract       Date:  2021-06-11

Review 4.  An expanded universe of cancer targets.

Authors:  William C Hahn; Joel S Bader; Theodore P Braun; Andrea Califano; Paul A Clemons; Brian J Druker; Andrew J Ewald; Haian Fu; Subhashini Jagu; Christopher J Kemp; William Kim; Calvin J Kuo; Michael McManus; Gordon B Mills; Xiulei Mo; Nidhi Sahni; Stuart L Schreiber; Jessica A Talamas; Pablo Tamayo; Jeffrey W Tyner; Bridget K Wagner; William A Weiss; Daniela S Gerhard
Journal:  Cell       Date:  2021-03-04       Impact factor: 41.582

Review 5.  White Matter Tracts and Diffuse Lower-Grade Gliomas: The Pivotal Role of Myelin Plasticity in the Tumor Pathogenesis, Infiltration Patterns, Functional Consequences and Therapeutic Management.

Authors:  Hugues Duffau
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

Review 6.  Electrotherapies for Glioblastoma.

Authors:  Elise P W Jenkins; Alina Finch; Magda Gerigk; Iasonas F Triantis; Colin Watts; George G Malliaras
Journal:  Adv Sci (Weinh)       Date:  2021-07-22       Impact factor: 16.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.